These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7461012)

  • 1. Changes in blood pressure, heart rate, and sympathetic activity on abrupt withdrawal of tiamenidine (HOE 440) in essential hypertension.
    Campbell BC; Elliott HL; Hamilton CA; Reid JL
    Eur J Clin Pharmacol; 1980 Nov; 18(6):449-54. PubMed ID: 7461012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abrupt withdrawal of the antihypertensive agent tiamenidine after 12-months' treatment.
    Gerlis LS; Wright N
    Pharmatherapeutica; 1980; 2(6):408-11. PubMed ID: 7001495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine.
    Hansson BG; Hökfelt B
    Br J Clin Pharmacol; 1981 Jan; 11(1):73-7. PubMed ID: 7011348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal phenomena in subjects with essential hypertension on clonidine or tiamenidine.
    Hamilton BP; Mersey JH; Hamilton J; Kuzbida G; Pavlis R; Levinson P
    Clin Pharmacol Ther; 1984 Nov; 36(5):628-33. PubMed ID: 6488684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).
    Findlay D; Lawrence JR
    Eur J Clin Pharmacol; 1978 Dec; 14(4):231-5. PubMed ID: 729618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.
    Reid JL; Wing LM; Dargie HJ; Hamilton CA; Davies DS; Dollery CT
    Lancet; 1977 Jun; 1(8023):1171-4. PubMed ID: 68274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular withdrawal effects of clonidine and tiamenidine on abrupt cessation of oral treatment in conscious cats.
    Finch L; Hicks PE
    J Pharm Pharmacol; 1980 Apr; 32(4):272-7. PubMed ID: 6103057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanfacine: effects of long-term treatment and withdrawal.
    Reid JL; Zamboulis C; Hamilton CA
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure and blood pressure variability following withdrawal of propranolol and clonidine.
    Neusy AJ; Lowenstein J
    J Clin Pharmacol; 1989 Jan; 29(1):18-24. PubMed ID: 2708545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regimen for the control of blood pressure and symptoms during clonidine withdrawal.
    Campbell BC; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal of guanfacine after long-term treatment in essential hypertension. Observations on blood pressure and plasma and urinary noradrenaline.
    Zamboulis C; Reid JL
    Eur J Clin Pharmacol; 1981 Jan; 19(1):19-24. PubMed ID: 7007059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal syndrome following cessation of antihypertensive drug therapy.
    Karachalios GN; Charalabopoulos A; Papalimneou V; Kiortsis D; Dimicco P; Kostoula OK; Charalabopoulos K
    Int J Clin Pract; 2005 May; 59(5):562-70. PubMed ID: 15857353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists.
    Reid JL; Campbell BC; Hamilton CA
    Hypertension; 1984; 6(5 Pt 2):II71-5. PubMed ID: 6150002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The withdrawal of centrally acting antihypertensives in dogs.
    Clough DP; Keddie J; Pettinger SJ
    Arzneimittelforschung; 1981; 31(11):1878-80. PubMed ID: 7198468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension.
    Planz G; Beckenbauer U; Bundschu HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):474-8. PubMed ID: 7141755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clonidine withdrawal: possible mechanisms and suggestions for management.
    Hunyor SN; Hansson L; Harrison TS; Hoobler SW
    Br Med J; 1973 Apr; 2(5860):209-11. PubMed ID: 4700009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of guanabenz withdrawal on blood pressure and plasma catecholamines.
    Buckalew VM; Burgess R; Strandhoy JW
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S830-2. PubMed ID: 6084134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine withdrawal. Mechanism and frequency of rebound hypertension.
    Geyskes GG; Boer P; Dorhout Mees EJ
    Br J Clin Pharmacol; 1979 Jan; 7(1):55-62. PubMed ID: 760743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin.
    Lederballe Pedersen O; Mikkelsen E; Lanng Nielsen J; Christensen NJ
    Eur J Clin Pharmacol; 1979 Apr; 15(3):215-7. PubMed ID: 37093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of central noradrenergic mechanisms in the rebound hypertension following clonidine withdrawal.
    Augustine SJ; Buckley JP; Tachikawa S; Lokhandwala MF
    J Cardiovasc Pharmacol; 1982; 4(3):449-55. PubMed ID: 6177942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.